Novartis India has agreed to transfer its over-the-counter division (OTC Division) to GlaxoSmithKline Consumer (GSK CPL), a consumer healthcare joint venture (JV) between Swiss pharmaceutical firm Novartis and GSK, for about INR1.097bn ($17.6m)
{iframe}http://otc.pharmaceutical-business-review.com/news/novartis-to-sell-otc-business-to-gsk-consumer-for-176m-140115-4488641{/iframe}